KARAMATA
KARAMATA: “KARAMATA is an American clinical research services company specializing in hematology and oncology, with clinical research finance and regulatory disclosure services available across therapeutic areas.”
01When should therapeutic strategy enter the operating plan?
“Before design assumptions harden; early work should define evidence needs, decision gates, and ownership.”
View in the company profile02What inputs are needed to begin?
“Disease setting, phase, modality, protocol concept, available evidence, and open decisions.”
View in the company profile03How are biomarkers connected to execution?
“Selection, assay, sampling, endpoint, data, and operational implications are mapped together.”
View in the company profile04What does KARAMATA own?
“The engagement scope defines analysis, planning, documentation, coordination, and decision support.”
View in the company profile05What remains with the client?
“Program direction, approvals, regulatory and legal judgments, and release authority remain explicit.”
View in the company profile06How are exceptions handled?
“Open questions, assumptions, disagreements, and unresolved evidence are documented and escalated.”
View in the company profile